AHPA in the News

By all accounts, the inaugural, virtual AHPA Sports Nutrition Congress hit it out of the ballpark!

With 225+ registrants, 20+ speakers, and 13 sponsors, the full-day event moved at a rapid pace, with informational nuggets and key takeaways from every session. Speakers from competing companies came together to share their insights, expertise and stories to help build a better industry. Registrants were the winners.

AHPA has released updates via the online Botanical Safety Handbook 2nd ed. to nine additional botanicals.

The American Herbal Products Association (AHPA) announces David Vobora, founder, Adaptive Training Foundation (ATF), will serve up inspiration with a side of never-give-up as he tells his story to attendees at the AHPA Sports Nutrition Congress taking place virtually on October 21.

Nutritional Outlook announced that AHPA President Michael McGuffin is one of 10 new members of the publication's editorial advisory board.

the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.

AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts. New safety information has been added to entries on 11 botanicals.

AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts.

In comments submitted to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), AHPA requests the agency to amend Phase VI of its import declarations enforcement schedule by removing “other” essential oils from the list of products covered under this phase.